ctrl K

Price Alert

Contineum Therapeutics In... (CTNM)

NASDAQ: CTNM · Real-Time Price · USD

9.08

0.98 (12.10%)

At close: Aug 19, 2025, 12:01 PM

Contineum Therapeutics Class A Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.94M	15.53M	5.57M	4.63M
Short-Term Investments	182.82M	109.66M	41.67M	64.37M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	3K	1.28M	129K	97K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.63M	2.52M	1.15M	775K
Total Current Assets	206.39M	127.71M	48.39M	69.78M
Property-Plant & Equipment	6.46M	1.4M	2.12M	642K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	6.46M	2.68M	2.24M	739K
Total Assets	212.85M	130.39M	50.64M	70.52M
Account Payables	1.81M	635K	430K	660K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	3.95M	1.25M
Other Current Liabilities	3.34M	2.48M	752K	1.01M
Total Current Liabilities	9.97M	5.48M	7.55M	3.67M
Long-Term Debt	n/a	192.62M	132.48M	3.66M
Other Long-Term Liabilities	n/a	110K	3.02M	134.08M
Total Long-Term Liabilities	4.81M	192.84M	136.3M	137.74M
Total Liabilities	14.78M	198.32M	143.85M	141.41M
Total Debt	6.26M	193.19M	138.33M	4.91M
Common Stock	26K	2K	12K	12K
Retained Earnings	-117.4M	-75.14M	-97.86M	-73.61M
Comprehensive Income	71K	108K	-76K	-35K
Shareholders Equity	198.07M	-67.94M	-93.21M	-70.89M
Total Investments	182.82M	109.66M	41.67M	64.37M